New York — The US Food and Drug Administration (FDA) plans to have an expert panel review any Covid-19 vaccine application for emergency use, and wants to see at least two months of safety data, according to a document posted by the agency on Tuesday.

The requirements will almost certainly add to the time it will take to review any vaccine, potentially past President Donald Trump’s goal of having one by election day next month. While the FDA has said it plans to work as quickly as possible, it has also said it won’t cut scientific corners or bend to political pressure to rush a vaccine...

BL Premium

This article is reserved for our subscribers.

A subscription helps you enjoy the best of our business content every day along with benefits such as articles from our international business news partners; ProfileData financial data; and digital access to the Sunday Times and Sunday Times Daily.

Already subscribed? Simply sign in below.

Questions or problems? Email or call 0860 52 52 00. Got a subscription voucher? Redeem it now